Marex Group plc [MRX] vs PJT Partners [PJT] Detailed Stock Comparison
Marex Group plc
NASDAQ
Loading...
PJT Partners
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Marex Group plc wins in 9 metrics, PJT Partners wins in 10 metrics, with 0 ties. PJT Partners appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Marex Group plc | PJT Partners | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.57 | 30.79 | Marex Group plc |
| Price-to-Book Ratio | 2.48 | 26.09 | Marex Group plc |
| Debt-to-Equity Ratio | 887.54 | 48.86 | PJT Partners |
| PEG Ratio | 11.74 | 2.30 | PJT Partners |
| EV/EBITDA | 1.94 | 15.84 | Marex Group plc |
| Profit Margin (TTM) | 10.14% | 10.43% | PJT Partners |
| Operating Margin (TTM) | 14.55% | 18.81% | PJT Partners |
| EBITDA Margin (TTM) | 14.55% | 18.81% | PJT Partners |
| Return on Equity | 26.52% | 31.56% | PJT Partners |
| Return on Assets (TTM) | 1.09% | 18.28% | PJT Partners |
| Free Cash Flow (TTM) | $1.14B | $527.65M | Marex Group plc |
| Dividend Yield | 2.01% | 0.49% | Marex Group plc |
| 1-Year Return | 48.60% | 43.84% | Marex Group plc |
| Price-to-Sales Ratio (TTM) | 0.98 | 4.65 | Marex Group plc |
| Enterprise Value | $1.68B | $5.25B | PJT Partners |
| EV/Revenue Ratio | 0.64 | 3.42 | Marex Group plc |
| Gross Profit Margin (TTM) | 38.83% | 31.96% | Marex Group plc |
| Revenue per Share (TTM) | $37 | $60 | PJT Partners |
| Earnings per Share (Diluted) | $3.31 | $5.84 | PJT Partners |
| Beta (Stock Volatility) | N/A | 0.76 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Marex Group plc vs PJT Partners Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Marex Group plc | -0.22% | 2.94% | -5.36% | -17.71% | -0.61% | 10.76% |
| PJT Partners | 3.10% | 0.52% | -1.97% | 22.26% | 13.27% | 15.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Marex Group plc | 48.60% | 89.58% | 89.58% | 89.58% | 89.58% | 89.58% |
| PJT Partners | 43.84% | 149.35% | 203.03% | 557.20% | 557.20% | 557.20% |
Performance & Financial Health Analysis: Marex Group plc vs PJT Partners
| Metric | MRX | PJT |
|---|---|---|
| Market Information | ||
| Market Cap | $2.55B | $7.14B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,212,790 | 225,180 |
| 90 Day Avg. Volume | 1,201,233 | 269,887 |
| Last Close | $36.02 | $180.73 |
| 52 Week Range | $22.33 - $49.34 | $116.07 - $190.27 |
| % from 52W High | -27.00% | -5.02% |
| All-Time High | $49.34 (May 12, 2025) | $190.27 (Feb 03, 2025) |
| % from All-Time High | -27.00% | -5.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.13% |
| Quarterly Earnings Growth | 0.29% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.10% |
| Operating Margin (TTM) | 0.15% | 0.19% |
| Return on Equity (TTM) | 0.27% | 0.32% |
| Debt to Equity (MRQ) | 887.54 | 48.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.14 | $6.89 |
| Cash per Share (MRQ) | $148.95 | $8.83 |
| Operating Cash Flow (TTM) | $1.64B | $490.66M |
| Levered Free Cash Flow (TTM) | $204.70M | $480.32M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.01% | 0.49% |
| Last 12-Month Dividend | $0.72 | $0.75 |
Valuation & Enterprise Metrics Analysis: Marex Group plc vs PJT Partners
| Metric | MRX | PJT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.57 | 30.79 |
| Forward P/E | 11.74 | 33.99 |
| PEG Ratio | 11.74 | 2.30 |
| Price to Sales (TTM) | 0.98 | 4.65 |
| Price to Book (MRQ) | 2.48 | 26.09 |
| Market Capitalization | ||
| Market Capitalization | $2.55B | $7.14B |
| Enterprise Value | $1.68B | $5.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.64 | 3.42 |
| Enterprise to EBITDA | 1.94 | 15.84 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.76 |
| Book Value per Share (MRQ) | $14.14 | $6.89 |
Financial Statements Comparison: Marex Group plc vs PJT Partners
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRX | PJT |
|---|---|---|
| Revenue/Sales | $865.70M | $324.53M |
| Cost of Goods Sold | $544.70M | $221.14M |
| Gross Profit | $321.00M | $103.39M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $239.30M | $58.58M |
| EBITDA | $247.90M | $66.12M |
| Pre-Tax Income | $98.00M | $52.58M |
| Income Tax | $25.50M | $-21.59M |
| Net Income (Profit) | $72.50M | $74.16M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRX | PJT |
|---|---|---|
| Cash & Equivalents | $2.61B | $194.27M |
| Total Current Assets | $23.78B | $532.90M |
| Total Current Liabilities | $21.77B | $89.56M |
| Long-Term Debt | $1.54B | $410.25M |
| Total Shareholders Equity | $1.05B | $824.31M |
| Retained Earnings | $775.30M | $276.35M |
| Property, Plant & Equipment | $86.80M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRX | PJT |
|---|---|---|
| Operating Cash Flow | N/A | $152.58M |
| Capital Expenditures | N/A | $-1.98M |
| Free Cash Flow | N/A | $-77.92M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-127.14M |
Short Interest & Institutional Ownership Analysis
| Metric | MRX | PJT |
|---|---|---|
| Shares Short | 3.16M | 2.03M |
| Short Ratio | 2.45 | 7.31 |
| Short % of Float | 0.09% | 0.10% |
| Average Daily Volume (10 Day) | 1,212,790 | 225,180 |
| Average Daily Volume (90 Day) | 1,201,233 | 269,887 |
| Shares Outstanding | 70.29M | 23.69M |
| Float Shares | 51.28M | 22.50M |
| % Held by Insiders | 0.25% | 0.07% |
| % Held by Institutions | 0.76% | 0.87% |
Dividend Analysis & Yield Comparison: Marex Group plc vs PJT Partners
| Metric | MRX | PJT |
|---|---|---|
| Last 12-Month Dividend | $0.72 | $0.75 |
| Last 12-Month Dividend Yield | 2.01% | 0.49% |
| 3-Year Avg Annual Dividend | $0.24 | $0.83 |
| 3-Year Avg Dividend Yield | 0.45% | 0.26% |
| 3-Year Total Dividends | $0.72 | $2.50 |
| Ex-Dividend Date | Aug 26, 2025 | Mar 05, 2025 |